The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
Open accessAbstract
Nearly two decades have passed since it was first proposed that regulation of the interconvertible sphingolipid metabolites, ceramide and sphingosine-1-phosphate (S1P), and their opposing signaling pathways are major determinants of cell fate, a concept referred to as the “sphingolipid rheostat”. Since then, many reports have substantiated the role of the sphingolipid rheostat in cell fate determination and in the initiation, progression, and drug sensitivity of cancer. Thus, modulation of the rheostat has emerged as a focus for treatment strategies to battle cancer. S1P regulates numerous processes important for cancer including proliferation, transformation, angiogenesis, metastasis, survival, and drug resistance. Ceramide on the other hand has been linked to cell growth arrest and cell death. With the increased understanding of sphingolipid metabolism and signaling, as well as the present focus on therapies designed to modulate the levels of sphingolipids in cancer, it is an appropriate time to re-examine the sphingolipid rheostat concept and determine how it fits within the current knowledge of sphingolipid signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Programmed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., & Spiegel, S. (1996) · Nature · doi:10.1038/381800a0 · Cited by 1,529
Self-citationCeramide-orchestrated signalling in cancer cells
Morad, S. A. F., & Cabot, M. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3398 · Cited by 1,014
Sphingosine-1-Phosphate as a Ligand for the G Protein-Coupled Receptor EDG-1
Lee, M.-J., Van Brocklyn, J. R., Thangada, S., Liu, C. H., Hand, A. R., Menzeleev, R., Spiegel, S., & Hla, T. (1998) · Science · doi:10.1126/science.279.5356.1552 · Cited by 1,007
Self-citationRegulation of histone acetylation in the nucleus by sphingosine-1-phosphate
Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., et al. (2009) · Science · doi:10.1126/science.1176709 · Cited by 997
Self-citationSphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens
Olivera, A., & Spiegel, S. (1993) · Nature · doi:10.1038/365557a0 · Cited by 889
Self-citationSphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., et al. (2010) · Nature · doi:10.1038/nature09128 · Cited by 752
Self-citationSphingosine-1-phosphate, a novel lipid, involved in cellular proliferation.
Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., & Spiegel, S. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.1.155 · Cited by 640
Self-citationLiang, J., Nagahashi, M., Kim, E. Y., Harikumar, K. B., Yamada, A., Huang, W.-C., Hait, N. C., Allegood, J. C., Price, M. M., Avni, D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.013 · Cited by 563
Self-citationTargeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Kunkel, G. T., Maceyka, M., Milstien, S., & Spiegel, S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4099 · Cited by 434
Self-citationRole of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility
Hobson, J. P., Rosenfeldt, H. M., Barak, L. S., Olivera, A., Poulton, S., Caron, M. G., Milstien, S., & Spiegel, S. (2001) · Science · doi:10.1126/science.1057559 · Cited by 426
Self-citationPharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
French, K. J., Zhuang, Y., Maines, L. W., Gao, P., Wang, W., Beljanski, V., Upson, J. J., Green, C. L., Keller, S. N., & Smith, C. D. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163444 · Cited by 317
Nagahashi, M., Ramachandran, S., Kim, E. Y., Allegood, J. C., Rashid, O. M., Yamada, A., Zhao, R., Milstien, S., Zhou, H., Spiegel, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2167 · Cited by 315
Self-citationSchnute, M. E., McReynolds, M. D., Kasten, T., Yates, M., Jerome, G., Rains, J. W., Hall, T., Chrencik, J., Kraus, M., Cronin, C. N., et al. (2012) · Biochemical Journal · doi:10.1042/bj20111929 · Cited by 280
Senkal, C. E., Ponnusamy, S., Bielawski, J., Hannun, Y. A., & Ogretmen, B. (2010) · The FASEB Journal · doi:10.1096/fj.09-135087 · Cited by 254
S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
Deng, J., Liu, Y., Lee, H., Herrmann, A., Zhang, W., Zhang, C., Shen, S., Priceman, S. J., Kujawski, M., Pal, S. K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.039 · Cited by 252
Sphingosine-1-Phosphate and Its Receptors: Structure, Signaling, and Influence
Rosen, H., Stevens, R. C., Hanson, M., Roberts, E., & Oldstone, M. B. A. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062411-130916 · Cited by 221
Hait, N. C., Wise, L. E., Allegood, J. C., O'Brien, M., Avni, D., Reeves, T. M., Knapp, P. E., Lu, J., Luo, C., Miles, M. F., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3728 · Cited by 209
Self-citationSphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver
Bektas, M., Allende, M. L., Lee, B. G., Chen, W., Amar, M. J., Remaley, A. T., Saba, J. D., & Proia, R. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081489 · Cited by 198
Molecular Basis of Sphingosine Kinase 1 Substrate Recognition and Catalysis
Wang, Z., Min, X., Xiao, S.-H., Johnstone, S., Romanow, W., Meininger, D., Xu, H., Liu, J., Dai, J., An, S., et al. (2013) · Structure · doi:10.1016/j.str.2013.02.025 · Cited by 187
Export of sphingosine-1-phosphate and cancer progression
Takabe, K., & Spiegel, S. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046656 · Cited by 163
Self-citationDegagné, É., Pandurangan, A. K., Bandhuvula, P., Kumar, A., Eltanawy, A., Zhang, M., Yoshinaga, Y., Nefedov, M. D., de Jong, P. J., Fong, L. G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74188 · Cited by 161
Regulation of Autophagy and Its Associated Cell Death by “Sphingolipid Rheostat”
Taniguchi, M., Kitatani, K., Kondo, T., Hashimoto-Nishimura, M., Asano, S., Hayashi, A., Mitsutake, S., Igarashi, Y., Umehara, H., Takeya, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416552 · Cited by 140
Evolving concepts in cancer therapy through targeting sphingolipid metabolism
Truman, J., García-Barros, M., Obeid, L. M., & Hannun, Y. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.12.013 · Cited by 134
Abuhusain, H. J., Matin, A., Qiao, Q., Shen, H. M., Kain, N., Day, B. W., Stringer, B. W., Daniels, B. J., Laaksonen, M. A., Teo, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.494740 · Cited by 133
Loveridge, C. J., Tonelli, F., Leclercq, T. M., Lim, K. G., Long, J. S., Berdyshev, E. V., Tate, R. J., Natarajan, V., Pitson, S. M., Pyne, N. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127993 · Cited by 120
Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640
Antoon, J. W., White, M. D., Meacham, W. D., Slaughter, E. M., Muir, S. E., Elliott, S. G., Rhodes, L. V., Ashe, H., Wiese, T. E., Smith, C. D., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0420 · Cited by 117
Liu, Y., Deng, J., Wang, L., Lee, H., Armstrong, B., Scuto, A., Kowolik, C. M., Weiss, L. M., Forman, S. J., & Yu, H. (2012) · Blood · doi:10.1182/blood-2011-12-399030 · Cited by 113
Venkata, J. K., An, N., Stuart, R. K., Costa, L. J., Cai, H., Coker, W. J., Song, J. H., Gibbs, K., Matson, T., Garrett-Mayer, E. S., et al. (2014) · Blood · doi:10.1182/blood-2014-03-559385 · Cited by 107
S1PR1 Is Crucial for Accumulation of Regulatory T Cells in Tumors via STAT3
Priceman, S. J., Shen, S., Wang, L., Deng, J., Yue, C., Kujawski, M., & Yu, H. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.016 · Cited by 104
Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate
Kharel, Y., Raje, M. R., Gao, M. Z., Gellett, A. M., Tomsig, J. L., Lynch, K. R., & Santos, W. L. (2012) · Biochemical Journal · doi:10.1042/bj20120609 · Cited by 100
Truth and consequences of sphingosine-1-phosphate lyase
Aguilar, A. G., & Saba, J. D. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.015 · Cited by 81
Sphingosine Kinases Are Not Required for Inflammatory Responses in Macrophages
Xiong, Y., Lee, H. J., Mariko, B., Lu, Y.-C., Dannenberg, A. J., Haka, A. S., Maxfield, F. R., Camerer, E., Proia, R. L., & Hla, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.483750 · Cited by 77
Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate
Kharel, Y., Mathews, T. P., Gellett, A. M., Tomsig, J. L., Kennedy, P., Moyer, M. L., Macdonald, T. L., & Lynch, K. R. (2011) · Biochemical Journal · doi:10.1042/bj20110817 · Cited by 74
Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability
Rex, K. L., Jeffries, S., Brown, M. L., Carlson, T. J., Coxon, A., Fajardo, F., Frank, B. T., Gustin, D. J., Kamb, A., Kassner, P. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068328 · Cited by 69
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
Nguyen-Tran, D.-H., Hait, N. C., Sperber, H., Qi, J., Fischer, K., Ieronimakis, N., Pantoja, M., Hays, A., Allegood, J., Reyes, M., et al. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.013631 · Cited by 58 · cited 1×
“S1P caused decreased HDAC activity and increased histone acetylation, and importantly suppressed dystrophic muscle degeneration [21].”
BackgroundSelf-citationIhlefeld, K., Claas, R. F., Koch, A. H., Pfeilschifter, J. M., & zu Heringdorf, D. M. (2012) · Biochemical Journal · doi:10.1042/bj20120811 · Cited by 41
ter Braak, M., Danneberg, K., Lichte, K., Liphardt, K., Ktistakis, N. T., Pitson, S. M., Hla, T., Jakobs, K. H., & zu Heringdorf, D. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.019 · Cited by 34
Ihlefeld, K., Vienken, H., Claas, R. F., Blankenbach, K. V., Rudowski, A., ter Braak, M., Koch, A., Veldhoven, P. P. V., Pfeilschifter, J. M., & zu Heringdorf, D. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m052761 · Cited by 27
Cited by
Ceramides and other sphingolipids as drivers of cardiovascular disease
Choi, R. H., Tatum, S. M., Symons, J. D., Summers, S. A., & Holland, W. L. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00536-1 · Cited by 387
Pyne, N. J., Adams, D. R., & Pyne, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.003 · Cited by 43
Proton-driven alternating access in a spinster lipid transporter
(2022) · doi:10.1038/s41467-022-32759-2 · Cited by 30
Metadata
- Authors
- Newton, J., Lima, S., Maceyka, M., & Spiegel, S.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 333
- Issue
- 2
- Pages
- 195-200
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W1994625058
- Cited by
- 282
- References
- 42
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.